A cyclometalated iridium complex
is reported where the core complex comprises naphthylpyridine as the
main ligand and the ancillary 2,2′-bipyridine ligand is attached
to a pyrene unit by a short alkyl bridge. To obtain the complex with
satisfactory purity, it was necessary to modify the standard synthesis
(direct reaction of the ancillary ligand with the chloro-bridged iridium
dimer) to a method harnessing an intermediate tetramethylheptanolate-based
complex, which was subjected to acid-promoted removal of the ancillary
ligand and subsequent complexation. The photophysical behavior of
the bichromophoric complex and a model complex without the pendant
pyrene were studied using steady-state and time-resolved spectroscopies.
Reversible electronic energy transfer (REET) is demonstrated, uniquely
with an emissive cyclometalated iridium center and an adjacent organic
chromophore. After excited-state equilibration is established (5 ns)
as a result of REET, extremely long luminescence lifetimes of up to
225 μs result, compared to 8.3 μs for the model complex,
without diminishing the emission quantum yield. As a result, remarkably
high oxygen sensitivity is observed in both solution and polymeric
matrices.
A doubly pyrene-grafted bis-cyclometallated iridium complex with engineered electronically excited states demonstrates reversible electronic energy transfer between adjacent chromophores giving rise to extremely long-lived red luminescence in solution (τ = 480 μs). Time-resolved spectroscopic studies afforded determination of pertinent photophysical parameters including rates of energy transfer and energy distribution between constituent chromophores in the equilibrated excited molecule (ca. 98% on the organic chromophores). Incorporation into a nanostructured metal-oxide matrix (AP200/19) gave highly sensitive O2 sensing films, as the detection sensitivity was 200-300% higher than with the commonly used PtTFPP and approaches the sensitivity of the best O2-sensing dyes reported to date.
A series of tris-heteroleptic iridium complexes of the form [Ir(C^N)(C^N)(acac)] combining 2-phenylpyridine (ppy), 2-(2,4-difluorophenyl)pyridine (dFppy), 1-phenylpyrazole (ppz), and 1-(2,4-difluorophenyl)pyrazole (dFppz) as the C^N ligands have been synthesized and fully characterized by NMR, X-ray crystallography, UV-vis absorption and emission spectroscopy, and electrochemical methods. It is shown that "static properties" (e.g., absorption and emission spectra and redox potentials) are primarily dictated by the overall architecture of the complex, while "dynamic properties" (e.g., excited-state lifetime and radiative and nonradiative rate constants) are, in addition, sensitive to the specific positioning of the substituents. As a result, the two complexes [Ir(dFppy)(ppz)(acac)] and [Ir(ppy)(dFppz)(acac)] have the same emission maxima and redox potentials, but their radiative and nonradiative rate constants differ significantly by a factor ∼2. Then acetylacetonate (acac) was replaced by picolinate (pic), and two pairs of diastereoisomers were obtained. As expected, the use of pic as the ancillary ligand results in blue-shifted emission, stabilization of the oxidation potential, and improvement of the photoluminescence quantum yield, and only minor differences in the optoelectronic properties are found between the two diastereoisomers of each pair.
A two-step process for the synthesis of trifluoromethyl-substituted cyclopropanes is described. Halothane, an anesthetic agent, is added to olefins in a ruthenium-catalyzed Kharasch reaction. The resulting 1,3-dihalides are converted into cyclopropanes by dehalogenation with magnesium. This procedure represents an alternative to metal-catalyzed cyclopropanations involving trifluoromethyl diazomethane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.